StockData
PDS Biotechnology Corp logo

PDS Biotechnology Corp (PDSB) stock

PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.89−0.03 (-3.28%)

Close on Nov 17, 2026Market cap $50.03MP/E –Yield –

PDS Biotechnology r&d expenses

Research and development expenses are spending on new products and technology.

PDS Biotechnology's R&D Expenses for the twelve months ending Jun 30, 2026 was $15.70M, down 26.5% year over year. For fiscal 2025 it was $19.03M, down 15.7% from the year before. Over ten years it grew 0.6% a year on average. The highest annual figure on record is $34.31M in fiscal 2017.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$19.03M-15.7%
FY2024Dec 31, 2024$22.57M-18.7%
FY2023Dec 31, 2023$27.76M-5.7%
FY2022Dec 31, 2022$29.43M+161.5%
FY2021Dec 31, 2021$11.25M+42.0%
FY2020Dec 31, 2020$7.92M+29.9%
FY2019Dec 31, 2019$6.10M+634.2%
FY2018Dec 31, 2018$830.74K-97.6%
FY2017Dec 31, 2017$34.31M+38.2%
FY2016Dec 31, 2016$24.83M+39.2%
FY2015Dec 31, 2015$17.84M+110.5%
FY2014Dec 31, 2014$8.47M+89.0%
FY2013Dec 31, 2013$4.48M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.27M-22.5%
Q1 FY2026Mar 31, 2026$3.46M-40.7%
Q4 FY2025Dec 31, 2025$4.41M-2.7%
Q3 FY2025Sep 30, 2025$4.58M-32.7%
Q2 FY2025Jun 30, 2025$4.21M-7.0%
Q1 FY2025Mar 31, 2025$5.83M-13.0%
Q4 FY2024Dec 31, 2024$4.53M-39.3%
Q3 FY2024Sep 30, 2024$6.80M+5.5%
Q2 FY2024Jun 30, 2024$4.53M-43.4%
Q1 FY2024Mar 31, 2024$6.70M+14.7%
Q4 FY2023Dec 31, 2023$7.47M-53.8%
Q3 FY2023Sep 30, 2023$6.45M+48.1%
Q2 FY2023Jun 30, 2023$8.00M+112.8%
Q1 FY2023Mar 31, 2023$5.84M+13.2%
Q4 FY2022Dec 31, 2022$16.16M+376.7%
Q3 FY2022Sep 30, 2022$4.35M+18.0%
Q2 FY2022Jun 30, 2022$3.76M+36.1%
Q1 FY2022Mar 31, 2022$5.16M+265.3%
Q4 FY2021Dec 31, 2021$3.39M+36.8%
Q3 FY2021Sep 30, 2021$3.69M+79.0%
Q2 FY2021Jun 30, 2021$2.76M+95.5%
Q1 FY2021Mar 31, 2021$1.41M-28.3%
Q4 FY2020Dec 31, 2020$2.48M+83.8%
Q3 FY2020Sep 30, 2020$2.06M+12.3%
Q2 FY2020Jun 30, 2020$1.41M-25.1%
Q1 FY2020Mar 31, 2020$1.97M+91.4%
Q4 FY2019Dec 31, 2019$1.35M+405.1%
Q3 FY2019Sep 30, 2019$1.83M+845.2%
Q2 FY2019Jun 30, 2019$1.89M+1019.1%
Q1 FY2019Mar 31, 2019$1.03M+412.1%
Q4 FY2018Dec 31, 2018$266.93K-97.5%
Q3 FY2018Sep 30, 2018$194.07K-97.2%
Q2 FY2018Jun 30, 2018$168.61K-98.1%
Q1 FY2018Mar 31, 2018$201.14K-97.3%
Q4 FY2017Dec 31, 2017$10.83M+59.8%
Q3 FY2017Sep 30, 2017$6.91M+2.8%
Q2 FY2017Jun 30, 2017$8.98M–
Q1 FY2017Mar 31, 2017$7.59M–
Q4 FY2016Dec 31, 2016$6.78M–
Q3 FY2016Sep 30, 2016$6.72M–

More PDS Biotechnology figures

See a number that looks wrong?